140 related articles for article (PubMed ID: 19904017)
1. Effect of repeated co-treatment with fluoxetine and amantadine on the behavioral reactivity of the central dopamine and serotonin system in rats.
Rogóz Z; Skuza G
Pharmacol Rep; 2009; 61(5):924-9. PubMed ID: 19904017
[TBL] [Abstract][Full Text] [Related]
2. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
Freo U; Merico A; Ermani M; Ori C
Brain Res; 2010 Jun; 1335():24-34. PubMed ID: 20381465
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats.
Rogóz Z; Skuza G
Pharmacol Rep; 2006; 58(4):493-500. PubMed ID: 16963794
[TBL] [Abstract][Full Text] [Related]
4. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
De Vry J; Schreiber R; Melon C; Dalmus M; Jentzsch KR
Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388
[TBL] [Abstract][Full Text] [Related]
5. Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray.
de Bortoli VC; Nogueira RL; Zangrossi H
Psychopharmacology (Berl); 2006 Jan; 183(4):422-8. PubMed ID: 16258751
[TBL] [Abstract][Full Text] [Related]
6. A dose-response study of separate and combined effects of the serotonin agonist 8-OH-DPAT and the dopamine agonist quinpirole on locomotor sensitization, cross-sensitization, and conditioned activity.
Johnson EF; Szechtman H
Behav Pharmacol; 2016 Aug; 27(5):439-50. PubMed ID: 26871406
[TBL] [Abstract][Full Text] [Related]
7. Repeated co-treatment with fluoxetine and amantadine induces brain-derived neurotrophic factor gene expression in rats.
Rogóz Z; Skuza G; Legutko B
Pharmacol Rep; 2008; 60(6):817-26. PubMed ID: 19211973
[TBL] [Abstract][Full Text] [Related]
8. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
[TBL] [Abstract][Full Text] [Related]
9. Role of 5-HT(1A) receptors in fluoxetine-induced lordosis inhibition.
Guptarak J; Sarkar J; Hiegel C; Uphouse L
Horm Behav; 2010 Jul; 58(2):290-6. PubMed ID: 20223238
[TBL] [Abstract][Full Text] [Related]
10. Effect of repeated treatment with tianeptine and fluoxetine on central dopamine D(2) /D(3) receptors.
Dziedzicka-Wasylewska M; Rogoz Z; Skuza G; Dlaboga D; Maj J
Behav Pharmacol; 2002 Mar; 13(2):127-38. PubMed ID: 11981225
[TBL] [Abstract][Full Text] [Related]
11. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
Zhang H; Wang W; Jiang Z; Shang J; Zhang L
Arzneimittelforschung; 2010; 60(3):109-15. PubMed ID: 20422941
[TBL] [Abstract][Full Text] [Related]
12. Effects of the antidepressant fluoxetine on the subcellular localization of 5-HT1A receptors and SERT.
Descarries L; Riad M
Philos Trans R Soc Lond B Biol Sci; 2012 Sep; 367(1601):2416-25. PubMed ID: 22826342
[TBL] [Abstract][Full Text] [Related]
13. Role of spinal serotonergic pathways in sneeze-induced urethral continence reflex in rats.
Miyazato M; Kaiho Y; Kamo I; Kitta T; Chancellor MB; Sugaya K; Arai Y; de Groat WC; Yoshimura N
Am J Physiol Renal Physiol; 2009 Oct; 297(4):F1024-31. PubMed ID: 19640898
[TBL] [Abstract][Full Text] [Related]
14. WAY100635 prevents the changes induced by fluoxetine upon the 5-HT1A receptor functionality.
Castro E; Díaz A; Rodriguez-Gaztelumendi A; Del Olmo E; Pazos A
Neuropharmacology; 2008 Dec; 55(8):1391-6. PubMed ID: 18809415
[TBL] [Abstract][Full Text] [Related]
15. Chronic fluoxetine-induced desensitization of 5-HT1A and 5-HT1B autoreceptors: regional differences and effects of WAY-100635.
Newman ME; Shalom G; Ran A; Gur E; Van de Kar LD
Eur J Pharmacol; 2004 Feb; 486(1):25-30. PubMed ID: 14751404
[TBL] [Abstract][Full Text] [Related]
16. Enhanced reactivity of 5-HT1A receptors in the rat dorsal periaqueductal gray matter after chronic treatment with fluoxetine and sertraline: evidence from the elevated T-maze.
Zanoveli JM; Nogueira RL; Zangrossi H
Neuropharmacology; 2007 Mar; 52(4):1188-95. PubMed ID: 17313964
[TBL] [Abstract][Full Text] [Related]
17. Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test.
Rénéric JP; Bouvard M; Stinus L
Neuropsychopharmacology; 2001 Apr; 24(4):379-90. PubMed ID: 11182533
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
van Amsterdam C; Seyfried CA
Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
[TBL] [Abstract][Full Text] [Related]
19. Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability.
Zazpe A; Artaiz I; Labeaga L; Lucero ML; Orjales A
Neuropharmacology; 2007 Mar; 52(3):975-84. PubMed ID: 17141811
[TBL] [Abstract][Full Text] [Related]
20. Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors.
D'Souza DN; Zhang Y; Garcia F; Battaglia G; Van De Kar LD
Psychopharmacology (Berl); 2002 Dec; 164(4):392-400. PubMed ID: 12457269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
